Viewing Study NCT00795418


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-06-16 @ 5:50 PM
Study NCT ID: NCT00795418
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2008-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Active immunization View
None Alzheimer's disease View
None Antibody View
None Vaccine View
None Central Nervous System Diseases View
None Neurodegenerative diseases View